Intellia Therapeutics, Inc. (NTLA)
13.13
-0.14
(-1.06%)
USD |
NASDAQ |
Apr 02, 16:00
13.12
-0.01
(-0.08%)
After-Hours: 20:00
Intellia Therapeutics Market Cap : 1.534B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.672B |
| Personalis, Inc. | 689.53M |
| Regeneron Pharmaceuticals, Inc. | 78.97B |
| Beam Therapeutics, Inc. | 2.557B |
| Pacific Biosciences of California, Inc. | 404.68M |
Market Cap Related Metrics
| PS Ratio | 21.02 |
| Price to Book Value | 2.310 |
| Price | 13.13 |
| Earnings Yield | -29.14% |